Regulation 2 Amendment of the Branded Health Service Medicines (Costs) Regulations 2018

(1)

The Branded Health Service Medicines (Costs) Regulations 2018^f1 are amended as follows.

(2)

In regulation 3 (payment scheme)—

(a)

in paragraph (1), for the table substitute the following table—

“

Table

Applicable Period Payment Percentage

1st July 2022 to the end of 2022 14.3%
2023 and any subsequent calendar year 24.4%

”;

Applicable Period	Payment Percentage
1st July 2022 to the end of 2022	14.3%
2023 and any subsequent calendar year	24.4%

(b)

in paragraph (1B)—

(i)

for “1st April 2020 to the end of 2020” substitute “1st July 2022 to the end of 2022”;

(ii)

for “5.0%” substitute “17.7%”, and

(iii)

for “7.4%” substitute “14.3%”; and

(c)

in paragraph (1C)—

(i)

for “1st April 2020 to the end of 2020” substitute “1st July 2022 to the end of 2022”;

(ii)

in sub-paragraph (a)—

(aa)

for “1st January 2020” substitute “1st January 2022”, and

(bb)

for “31st March 2020” substitute “30th June 2022”, and

(iii)

in sub-paragraph (b), for “14.7%” substitute “10.9%”.

Annotations

f1: S.I. 2018/345; relevant amending instruments are S.I. 2018/1255 and S.I. 2020/258.